Skip to content
afatinib

Structure via PubChem · Public domain (PubChem)

EntityQ4688818· pop 21· linked from 503 articles

Also known as BIBW2992, Gilotrif®, BIBW 2992, Afatinibum

Afatinib, sold under the brand name Gilotrif among others, is a medication which is used to treat non-small cell lung carcinoma (NSCLC). It belongs to the tyrosine kinase inhibitor family of medications. It is taken by mouth.

Key facts

Drug.licence_EU
yes
Drug.protein_bound
95%
Drug.Verifiedfields
changed
Drug.verifiedrevid
645735594
Drug.image
Afatinib2DACS.svg
Drug.image_class
skin-invert-image
Drug.image2
Afatinib 3D ball-and-stick 4G5P.png
Drug.image_class2
bg-transparent
Drug.tradename
Gilotrif, Giotrif, Afanix
Drug.MedlinePlus
a613044
Drug.DailyMedID
Afatinib
Drug.pregnancy_AU
C
Drug.routes_of_administration
By mouth
Drug.ATC_prefix
L01
Drug.ATC_suffix
EB03
Drug.legal_AU
S4
Drug.legal_CA
Rx-only
Drug.legal_UK
POM

via Wikipedia infobox

Chemical data

Formula
C24H25ClFN5O3
Molecular weight
485.9 g/mol
IUPAC name
(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
SMILES
CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4
InChIKey
ULXXDDBFHOBEHA-CWDCEQMOSA-N
XLogP
3.6
Polar surface area
88.6 Ų
H-bond donors
2
H-bond acceptors
8
Formal charge
0

via PubChem

Research

2,631 papers

via PubMed

Wikidata facts

Mass
485.163
Show 5 more facts
chemical formula
C₂₄H₂₅ClFN₅O₃
isomeric SMILES
CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4
canonical SMILES
CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4
World Health Organisation international non-proprietary name
afatinib
Commons category
Afatinib
Sources (5)

via Wikidata · CC0

~4 min read

Article

6 sections
Contents
  • Medical uses
  • Adverse effects
  • Mechanism of action
  • Clinical trials
  • References
  • External links

Afatinib, sold under the brand name Gilotrif among others, is a medication which is used to treat non-small cell lung carcinoma (NSCLC). It belongs to the tyrosine kinase inhibitor family of medications. It is taken by mouth.

It is mainly used to treating cases of NSCLC that harbour mutations in the epidermal growth factor receptor (EGFR) gene.

Gallery (2)

Connections

Categories